ursolic acid has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WJ; Ciric, B; Curtis, MT; Li, X; Rostami, A; Zhang, GX; Zhang, Y | 1 |
| Ding, S; Dong, C; Nurieva, RI; Wang, X; Xu, T; Zhong, B | 1 |
2 other study(ies) available for ursolic acid and Allergic Encephalomyelitis
| Article | Year |
|---|---|
A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Topics: Animals; Astrocytes; Cell Differentiation; Corpus Callosum; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Immunomodulation; Male; Mice; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; PPAR gamma; Remyelination; Triterpenes; Ursolic Acid | 2020 |
Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein.
Topics: Animals; Anti-Infective Agents; Cell Differentiation; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Humans; Interleukin-17; Mice; Neoplasms; Nuclear Receptor Subfamily 1, Group F, Member 3; Th17 Cells; Triterpenes; Ursolic Acid | 2011 |